Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen
This study has been completed.
Study NCT00332553 Information provided by Eli Lilly and Company
First Received: May 30, 2006 Last Updated: May 11, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Vasomotor Symptoms
Endometrial Safety
Interventions listed in this trial
Raloxifene
medroxyprogesterone acetate
estrogen
17 beta estradiol
Additional drug interventions recognized in this trial
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Estrogens
Medroxyprogesterone
Medroxyprogesterone 17-Acetate
Polyestradiol phosphate
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Estrogen Antagonists
Estrogen Receptor Modulators
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Selective Estrogen Receptor Modulators
Therapeutic Uses
Sponsors listed in this trial
Eli Lilly and Company
Back to top of Main Content
